Note 1 - Organization and Consolidation

12 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Nature of Operations [Text Block]

NOTE

1

– ORGANIZATION AND CONSOLIDATION

CEN Biotech, Inc. (“CEN” or the “Company”) was incorporated in Canada on

August

4,

2013

as a subsidiary of Creative Edge Nutrition, Inc. (“Creative”), a public company incorporated in Nevada. Creative distributed the shares of CEN common stock on a pro rata basis to the Creative shareholders on

February

29,

2016

at which time CEN became an independent public company.

CEN is an early stage Canadian biopharmaceutical company founded to integrate agronomical and pharmaceutical principles for the purposes of growing, selling, processing and delivering pharmaceutical-grade medical marijuana in its pure and extracted form to patients in accordance with Health Canada’s newly-formed Marihuana for Medical Purposes Regulations (MMPR).

CEN is actively pursuing business opportunities globally with the intent to grow, sell, process and deliver pharmaceutical grade medical marijuana in various drug delivery mechanisms within nations where it is legal.

The company’s financial statement are consolidated and include the accounts of CEN Biotech Inc. and CEN Holdings Inc. CEN Holdings Inc. was incorporated in Michigan as a non-operating wholly owned subsidiary of CEN Biotech Inc. Its purpose is to ease and facilitate US banking transactions. Intercompany transactions are eliminated in consolidation.